April 23 (Reuters) - Australian Pharmaceutical Industries Ltd (API) :
- FOR HY ENDING FEB, NPAT $22.5 MILLION VERSUS $25 MILLION
- FOR HY ENDING FEB, REVENUE FROM ORDINARY ACTIVITIES $2.03 BILLION VERSUS $1.98 BILLION
Source text https://reut.rs/2zoaqF7
(([email protected];))
- Forums
- ASX - By Stock
- News: API Australian Pharmaceutical Industries Says For HY Ending Feb, NPAT $22.5 Mln
April 23 (Reuters) - Australian Pharmaceutical Industries Ltd...
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online